Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels [1]

Clinical and Experimental Rheumatology

Volumn 19, Issue 5, 2001, Pages 595-

  Beutler, A M ^a   Rull, M ^a   Schlesinger, N ^a   Baker, D G ^a   Hoffman, B I ^a   Schumacher B I , Jr ^a  

^a Riddle Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIINFLAMMATORY AGENT; CREATININE; URATE; URIC ACID;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FOLLOW UP; GOUT; HUMAN; LETTER; MALE; MEDICAL RECORD; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; UNITED STATES; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; AGED; ALLOPURINOL; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URIC ACID;

EID: 0034821448     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Gout and hyperuricemia
2. Management of hyperuricemia
3. Epidemiology of gout and hyperuricemia. A long-term population study
4. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study
5. New uses of allopurinol
6. Role of xanthine oxidase and its inhibitor in hypoxia: Reoxygenation injury
7. Effects of allopurinol on in vivo suppression of arthritis in mice and ex vivo modulation of phagocytic production of oxygen radicals in whole human blood
8. Inhibitory effect of allopurinol on adjuvant arthritis in rats
9. Effect of high lipid diet and allopurinol on the development of experimentally induced arthritis in rats